Neogen Corporation

Neogen Corporation

NEOGยทNASDAQ

$8.81

-1.2%
HealthcareMedical - Diagnostics & Research

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

At a Glance

Live Snapshot
Market Cap$1.92B
EPS-5.0300
P/E Ratio-1.75
Earnings Date07/28/2026
3Y+247.0%
5Y+332.0%
10Y+662.0%
3Y+1200.0%
5Y+1806.0%
10Y+2786.0%
3Y+133.0%
5Y+186.0%
10Y+413.0%
neog

Neogen Corporation Funding & Solvency Profile

NEOG ยท NASDAQ
Cash & Cash Equivalents129.00M
Net Receivables153.38M
Inventory190.86M
Other Current Assets103.69M
Total Current Assets577 M
Property, Plant & Equipment356.28M
Goodwill & Intangible Assets2.48B
Long-Term Investments0.00
Other Non-Current Assets35.23M
Total Non-Current Assets392 M
Total Assets
3.44B

Financial Health Analysis

Current Ratio

3.32x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.66x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

403 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

17% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Neogen Corporation Balance Sheet

NEOG โ€ข NASDAQ

Neogen Corporation Balance SheetMay 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010May 2009May 2008May 2007May 2006
ASSETS
CURRENT ASSETS
129M
170.6M
163.2M
44.5M
75.6M
66.3M
41.7M
83.1M
77.6M
55.3M
66.1M
40.7M
50M
49M
35.8M
22.8M
13.8M
14.3M
13.4M
1.8M
0.0
325K
82.3M
336.6M
305.5M
277.4M
225.8M
127.7M
66.1M
52.5M
48.1M
35.8M
35.3M
19.6M
20.2M
0.0
0.0
0.0
0.0
150K
129M
170.9M
245.6M
381.1M
381.1M
343.7M
267.5M
210.8M
143.6M
107.8M
114.2M
76.5M
85.4M
68.6M
56.1M
22.8M
13.8M
14.3M
13.4M
2M
153.4M
173M
153.3M
99.7M
91.8M
84.7M
82.6M
79.1M
68.6M
67.7M
59.2M
51.9M
38.7M
35.7M
28.6M
27.4M
23.4M
19.4M
14.9M
13.1M
153.4M
173M
153.3M
99.7M
91.8M
84.7M
82.6M
79.1M
68.6M
67.7M
59.2M
51.9M
38.7M
35.7M
28.6M
27.4M
23.4M
19.4M
14.9M
13.1M
190.9M
189.3M
133.8M
122.3M
100.7M
95.1M
86M
76M
73.1M
64.4M
51.6M
51.2M
38.3M
35M
32M
31.3M
31.4M
27.8M
19.1M
17.6M
0.0
0.0
0.0
23.8M
17.8M
14M
13.4M
9.9M
7.6M
8.4M
4.2M
7.5M
4.6M
3.3M
4.7M
3.7M
3M
3M
2.9M
2.3M
103.7M
56M
53.3M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2M
1.7M
1.5M
1.3M
1M
774K
200K
1.2M
787K
1.3M
576.9M
589.2M
585.9M
626.8M
591.5M
537.4M
449.5M
375.8M
293M
250M
231.2M
188.7M
168.4M
143.9M
122.5M
86M
71.8M
65.6M
51.1M
36.3M
NON-CURRENT ASSETS
356.3M
291.9M
198.7M
110.6M
100.5M
78.7M
74.8M
73.1M
61.7M
54.7M
44.5M
41.9M
34.3M
29.9M
22.3M
19.2M
17.1M
16.9B
16.4M
14.3M
1.1B
2.1B
2.1B
142.7M
131.5M
110.3M
103.6M
99.6M
104.8M
88.5M
70.1M
68.2M
59.5M
53.1M
51.6M
52.9M
39.7M
30.6M
24.4M
28.9M
1.4B
1.5B
1.6B
107.5M
92.3M
66.6M
67.6M
69.6M
68.9M
58.5M
46.4M
46.4M
28.3M
24.7M
17.2M
17.2M
9.9M
9.6M
9.4M
2.1M
2.5B
3.6B
3.7B
250.2M
223.8M
176.9M
171.2M
169.2M
173.7M
147M
116.5M
114.6M
87.8M
77.7M
68.8M
75M
49.6M
40.2M
33.8M
31M
0.0
229K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-5.7M
-200M
0.0
-1.4B
0.0
0.0
0.0
19.4M
6.9M
3.9M
3.5M
15.6M
4M
6.8M
1.8M
0.0
1.7M
1.5M
1.3M
1M
774K
200M
1.2B
1.4B
2B
35.2M
20.2M
7.8M
-1.6M
620K
647K
-15.5M
-4M
-6.8M
-1.8M
0.0
-1.7M
0.0
-1.3M
5M
9.9M
3.8M
-18.1B
4M
-2B
2.9B
4B
4B
366.1M
328.7M
259.8M
246.2M
242.2M
235.4M
201.7M
161M
156.6M
120.8M
107.7M
97.2M
94.2M
70.4M
60.7M
54.2M
52M
3.4B
4.5B
4.6B
992.9M
920.2M
797.2M
695.7M
618M
528.4M
451.7M
392.2M
345.3M
289.3M
251.6M
219.7M
180.2M
142.2M
126.4M
105.3M
88.3M
LIABILITIES
CURRENT LIABILITIES
85.2M
93.5M
83.6M
36.7M
25.7M
27.1M
19.1M
20.8M
16.2M
15.8M
13.7M
13.4M
9.4M
11.6M
8.5M
10M
4.6M
6.5M
5.9M
3.7M
79.6M
83.1M
76.7M
34.6M
23.9M
25.7M
19.1M
20.8M
16.2M
15.8M
13.7M
13.4M
9.2M
10.8M
8.5M
7.2M
3.9M
6.5M
4.5M
2.8M
5.6M
10.4M
7M
2.1M
1.8M
1.5M
0.0
0.0
0.0
0.0
0.0
0.0
165K
809K
0.0
2.8M
667K
0.0
1.4M
876K
11.1M
19.9M
25.2M
24.5M
23.2M
20.3M
7.1M
6.1M
5M
12.8M
10.5M
11.6M
3.2M
2.8M
2.7M
2.3M
3.2M
4.3M
1.7M
1.6M
19.3M
2.4M
3.3M
0.0
1.3M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
8.1M
7.5M
3.3M
0.0
0.0
1.1M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.6M
10.4M
7M
2.1M
1.8M
1.5M
601K
165K
936K
0.0
1.3M
0.0
165K
809K
0.0
0.0
0.0
0.0
1.4B
876M
5.6M
4.6M
4.6M
5.5M
3.4M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
44.8M
26.2M
25.5M
11.1M
0.0
0.0
12.1M
11.9M
14.8M
0.0
0.0
0.0
5.1M
5.7M
6.6M
4.7M
1.5M
302K
2.4M
4.7M
174M
154.3M
145.5M
77.8M
53.6M
48.5M
38.3M
38.7M
36M
28.6M
25.5M
25M
17.7M
20M
17.8M
17M
9.2M
11.1M
10M
10M
NON-CURRENT LIABILITIES
874.8M
888.4M
885.4M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
10M
280.9M
326.7M
353.4M
17M
21.9M
18.1M
15.6M
14.1M
17M
16.5M
13.7M
12.2M
12.4M
10M
8.3M
5.8M
2.7M
2.3M
1.4M
2M
30M
25M
27.1M
10.7M
4.3M
5.4M
4M
5M
3.6M
2.4M
2.1M
1.9M
2.1M
2.6M
4.5M
4.3M
1.5M
1.6M
1.9M
913K
1.2B
1.3B
1.3B
27.7M
26.2M
23.5M
19.6M
19.1M
20.7M
19M
15.8M
14M
13.2M
12.6M
12.9M
10.1M
4.3M
4M
3.3M
12.8M
20.9M
17.8M
12.1M
0.0
0.0
913.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4B
1.4B
1.4B
105.6M
79.8M
72M
57.8M
57.8M
56.7M
47.6M
41.2M
39M
31M
32.5M
30.7M
27.2M
13.5M
15.1M
13.3M
23.7M
SHAREHOLDERS' EQUITY
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
64K
0.0
0.0
0.0
0.0
34.7M
34.7M
34.6M
17.2M
17.2M
16.9M
8.4M
8.3M
8.1M
6M
5.9M
5.9M
5.8M
3.8M
3.7M
3.6M
2.4M
2.3M
1.5M
1.3M
2.6B
2.6B
2.6B
310M
295M
249.2M
221.9M
202.6M
174.7M
150M
131.9M
118.1M
99.9M
89.6M
81.2M
69.6M
63.2M
58.8M
51.7M
35.5M
-536.4M
555.6M
565M
587.9M
539.6M
478.7M
419.2M
359.1M
295.9M
252.1M
215.6M
182M
153.9M
126.7M
104.1M
81.2M
63.6M
49.7M
37.6M
34.5M
-28.9M
-30M
-33.3M
-27.8M
-11.4M
-19.7M
-11.6M
-9.7M
-7.2M
-3.9M
-2.4M
371K
-1.4M
-1.2M
-394K
-1.7M
-430K
421K
386K
85K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
215K
0.0
388K
0.0
0.0
748K
-876K
2.1B
3.1B
3.1B
887.4M
840.4M
725.2M
637.9M
560.2M
471.8M
404.2M
351M
306.3M
258.3M
219.1M
188.6M
153.1M
128.7M
111.2M
91.9M
64.5M
2.1B
3.1B
3.1B
887.4M
840.4M
725.2M
637.9M
560.2M
471.9M
404.1M
351M
306.2M
258.4M
219.3M
189M
153.4M
128.7M
111.2M
91.9M
64.5M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
143K
-37K
-11K
-61K
66K
215K
333K
388K
0.0
0.0
0.0
0.0
SUMMARY
3.4B
4.5B
4.6B
992.9M
920.2M
797.2M
695.7M
618M
528.4M
451.7M
392.2M
345.3M
289.3M
251.6M
219.7M
180.2M
142.2M
126.4M
105.3M
88.3M
0.0
554K
82.3M
336.6M
305.5M
277.4M
225.8M
127.7M
66.1M
52.5M
48.1M
35.8M
35.3M
19.6M
20.2M
-5.7M
-203.8M
0.0
-1.4B
150K
912.6M
906.2M
897.5M
0.0
1.3M
1.1M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
10M
783.6M
735.6M
734.3M
-44.5M
-74.3M
-65.2M
-41.7M
-83.1M
-77.6M
-55.3M
-66.1M
-40.7M
-50M
-49M
-35.8M
-8.8M
-8.5M
-14.3M
-2M
8.1M
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626
217,298,626

SEC Filings

NEOG - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

April 20, 2026
April 20, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 09, 2026
February 28, 2026
2026
8-K

8-K 2026

N/A

April 09, 2026
April 09, 2026
2026
8-K

8-K 2026

N/A

March 30, 2026
March 30, 2026
2026
8-K

8-K 2026

N/A

January 08, 2026
January 08, 2026
2026
10-Q

10-Q 2025 Q4

Q4

January 08, 2026
November 30, 2025
2025
8-K

8-K 2025

N/A

October 30, 2025
October 30, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

October 28, 2025
August 14, 2025
2025
8-K

8-K 2025

N/A

October 27, 2025
October 23, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

October 27, 2025
October 23, 2025
2025
Showing 1 to 10 of 393 filings